Five eyes had previously received treatment with anti-VEGF injections due to neovascular age-related macular degeneration (nAMD), with an average of 21.8 ± 14.3 prior intravitreal injections, while the remaining 32 eyes were treatment naïve. Here, VEGFA is linked to wet macular degeneration.